Molecular epidemiology and patient outcome of carbapenem-resistant <i>Enterobacterales, Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> in Japan: a multicenter study from MultiDrug-Resistant organisms clinical research network
Sho Saito(National Center for Global Health and Medicine), Yohei Doi(Fujita Health University), Kohei Uemura(The University of Tokyo), Kazufumi Hiramatsu(Oita University), Haruki Mito(Japanese Red Cross Narita Hospital), Koh Shinohara(Kyoto University), Yasufumi Matsumura(Kyoto University), Yasunobu Endo(Japanese Red Cross Narita Hospital), Masahiro Suzuki(Fujita Health University), Kayoko Sano(Yokohama City University Hospital), Keiichiro Mori(Jikei University School of Medicine), Shoki Izumi(The University of Tokyo), Naoya Itoh(Aichi Cancer Center), Nana Akazawa(Nagoya City University), Tetsuya Suzuki(National Institute of Infectious Diseases), Takashi Matono(Aso Iizuka Hospital), Ryota Hase(Fujita Health University), Yusuke Asai, Norio Ohmagari(National Center for Global Health and Medicine), David van Duin(University of North Carolina at Chapel Hill), Aki Sakurai(Fujita Health University), Hideaki Kato(Yokohama City University Hospital), Takehiro Hashimoto(Oita University Hospital), Kayoko Hayakawa(National Center for Global Health and Medicine), Jiefu Yu(National Center for Global Health and Medicine), Mari Kurokawa(Fujita Health University)
Cited by 3
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Cloning of a Novel Gene for Quinolone Resistance from a Transferable Plasmid in <i>Shigella flexneri</i> 2b
|Antimicrobial Agents and Chemotherapy|2005|290
Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed
|Archive ouverte UNIGE (University of Geneva)|2022|221